Results for tag: "Rare Disease"

The Rare Disease market is a subset of the Healthcare Services industry that focuses on the diagnosis, treatment, and management of rare diseases. Rare diseases are defined as those that affect a small percentage of the population, and are often chronic, progressive, and life-threatening. Treatment for rare diseases is often complex and expensive, and requires specialized care. As such, the Rare Disease market is comprised of a variety of stakeholders, including pharmaceutical companies, healthcare providers, patient advocacy groups, and government agencies. Companies in the Rare Disease market include AbbVie, Alexion Pharmaceuticals, Amicus Therapeutics, BioMarin Pharmaceuticals, and Shire. These companies develop and market treatments for rare diseases, as well as provide support services for patients and their families. Additionally, patient advocacy groups such as the National Organization for Rare Disorders (NORD) provide resources and support to those affected by rare diseases. Show Less Read more